Pharmaceuticals

Oncology Precision Medicine Market Revenue Growth Forecast To Reach $23.74 Billion By 2030 At 8.9% CAGR

May 1, 2026May 6, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Oncology Precision Medicine Market Projected To Reach By 2030?

The oncology precision medicine market size has seen rapid expansion in recent years. It is anticipated to grow from $125.14 billion in 2025 to $141.22 billion in 2026, registering a compound annual growth rate (CAGR) of 12.9%. The historical growth of this market can be attributed to factors such as the limited availability of genomic testing, a reliance on standard chemotherapy protocols, an increasing prevalence of cancer, the early advancements in molecular diagnostics, and the establishment of hospital-based oncology research programs.

The oncology precision medicine market is projected to experience rapid expansion over the coming years, with its valuation anticipated to reach $226.55 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 12.5%. This projected growth during the forecast period stems from various factors, including breakthroughs in CAR-T and gene therapies, an increase in targeted kinase and immune checkpoint inhibitors, greater investments in precision oncology research, the incorporation of bioinformatics and AI into clinical decision-making processes, and the expansion of biomarker-guided clinical trials. Key trends expected over the forecast period encompass a growing acceptance of personalized cancer therapies, more widespread utilization of companion diagnostics and molecular diagnostics, advancements in liquid biopsy and next-generation sequencing assays, an expansion of targeted therapeutics and monoclonal antibodies, and an intensified focus on patient stratification based on biomarkers.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25853&type=smp

What Primary Drivers Are Shaping The Oncology Precision Medicine Market?

The increasing incidence of cancer is projected to fuel the expansion of the oncology precision medicine market in the future. Cancer refers to an illness characterized by the unchecked proliferation of aberrant cells, capable of metastasizing to various bodily regions and impairing typical physiological processes. This rise in cancer prevalence stems from aging demographics, where extended lifespans contribute to the buildup of deoxyribonucleic acid (DNA) mutations, impaired repair mechanisms, persistent inflammaging, declining immune vigilance, and tissue microenvironments that progressively favor tumor development. Oncology precision medicine offers benefits for cancer patients by delivering customized therapies tailored to the distinct genetic profile of individual tumors, thereby enhancing efficacy and minimizing adverse reactions. For example, the World Health Organization (WHO), a Switzerland-based intergovernmental body, reported in February 2024 that the approximately 20 million new cancer cases in 2022 are predicted to surge by 77% to exceed 35 million cases by 2050. Consequently, the escalating occurrence of cancer is a key factor propelling the expansion of the oncology precision medicine market.

What Are The Key Segment Divisions In The Oncology Precision Medicine Market Segment Structure?

The oncology precision medicine market covered in this report is segmented –

1) By Product Type: Diagnostics, Therapeutics, Inhibitor Drugs, Monoclonal Antibodies, Cell And Gene Therapy, Antiviral And Anti-Retroviral Drugs

2) By Technology: Genomics, Proteomics, Bioinformatics, Other Technologies

3) By Biomarker Types: Genetic Biomarkers, Protein Biomarkers, Epigenetic Biomarkers, Metabolic Biomarkers, Other Biomarker Types

4) By Applications: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer, Kidney Cancer, Liver Cancer, Bladder Cancer, Other Applications

5) By End-Users: Hospitals, Diagnostic Laboratories, Research Institutions, Pharmaceutical Companies, Other End-Users

Subsegments:

1) By Diagnostics: Companion Diagnostics, Molecular Diagnostics, Liquid Biopsy, Imaging Diagnostics, Next-Generation Sequencing Assays

2) By Therapeutics: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

3) By Inhibitor Drugs: Tyrosine Kinase Inhibitors (TKIs), Poly ADP-Ribose Polymerase Inhibitors (PARP Inhibitors), Cyclin-Dependent Kinase 4 And 6 Inhibitors (CDK4/6 Inhibitors), B-Raf Proto-Oncogene Serine Or Threonine Kinase Inhibitors (BRAF Inhibitors), Mitogen-Activated Protein Kinase Kinase Inhibitors (MEK Inhibitors)

4) By Monoclonal Antibodies: Naked Monoclonal Antibodies, Conjugated Monoclonal Antibodies, Bispecific Antibodies, Immune Checkpoint Inhibitors, Radiolabeled Antibodies

5) By Cell And Gene Therapy: CAR-T Cell Therapies, T-Cell Receptor (TCR) Therapies, Tumor-Infiltrating Lymphocyte (TIL) Therapies, Oncolytic Viral Therapies, Gene Editing And Replacement Therapies

6) By Antiviral And Anti-Retroviral Drugs: Reverse Transcriptase Inhibitors, Protease Inhibitors, Integrase Strand Transfer Inhibitors, Entry Inhibitors, Antiviral Agents Targeting Virus-Related Cancers

What Market Trends Are Affecting The Oncology Precision Medicine Market?

Key companies within the oncology precision medicine market are concentrating on creating innovative solutions, such as molecular tumor board programs, to encourage multidisciplinary cooperation and refine individualized treatment planning. Molecular tumor boards consist of expert teams from various fields who assess and interpret intricate genetic and molecular test findings to recommend tailored cancer treatment approaches. For example, in April 2025, McKesson Corporation, a US-based healthcare services and information technology company, unveiled the Precision Care Companion initiative. This program is designed to support biomarker-driven cancer care by delivering education, technological advancements, and operational aid to oncology practices. This extensive initiative unites physicians, clinical staff, business leaders, and pharmaceutical partners to foster a collaborative setting, which expedites the incorporation of advanced genomic testing and targeted therapies, ultimately enabling providers to deliver more personalized and effective cancer treatments while improving patient outcomes.

Which Organizations Are Engaged In The Oncology Precision Medicine Market?

Major companies operating in the oncology precision medicine market are Roche Holding AG, Bristol Myers Squibb Company, Abbott Laboratories, Novartis AG, Gilead Sciences Inc., Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Agilent Technologies Inc., Illumina Inc., bioMérieux S.A., Bio-Rad Laboratories Inc., Exact Sciences Corporation, Almac Group Limited, OPKO Health Inc., Natera Inc., Myriad Genetics Inc., Pacific Biosciences of California Inc., Asuragen Inc., BGI Group, ANGLE plc.

Get The Full Oncology Precision Medicine Market Report:

https://www.thebusinessresearchcompany.com/report/oncology-precision-medicine-global-market-report

Which Region Leads The Oncology Precision Medicine Market In Overall Market Size?

North America was the largest region in the oncology precision medicine market in 2025. The regions covered in the oncology precision medicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Oncology Precision Medicine Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/oncology-precision-medicine-global-market-report

Browse Through More Reports Similar to the Global Oncology Precision Medicine Market 2026, By The Business Research Company

Precision Medicine Market Report 2026

https://www.thebusinessresearchcompany.com/report/precision-medicine-global-market-report

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Oncology Drugs Market 2026

https://www.thebusinessresearchcompany.com/report/oncology-drugs-market

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795